FERACCRU

This brand name is authorized in Austria, Estonia, Finland, Croatia, Ireland, Lithuania, Poland, United Kingdom

Active ingredients

The drug FERACCRU contains one active pharmaceutical ingredient (API):

1 Iron(III)-maltol UNII MA10QYF1Z0 - FERRIC MALTOL

Iron in a stable ferric state as a complex with a trimaltol ligand. The complex is designed to provide, in a controlled way, utilisable iron for uptake across the intestinal wall and transfer to the iron transport and storage proteins in the body (transferrin and ferritin, respectively). The complex dissociates on uptake from the gastro-intestinal tract and the complex itself does not enter the systemic circulation. Read about Ferric maltol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FERACCRU Capsules, hard	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B03AB10		B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AB Iron trivalent, oral preparations
Discover more medicines within B03AB10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1713428
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 076534
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 325766
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1079688, 1093328
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100366838